loading

Roivant Sciences Ltd Stock (ROIV) Latest News

pulisher
Mar 19, 2025

Roivant Phase III Batoclimab Trial Is Positive, But No Filing Planned - Scrip

Mar 19, 2025
pulisher
Mar 19, 2025

Roivant Sciences Says Phase 3 MG Study Meets Primary Endpoint -March 19, 2025 at 08:24 am EDT - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Roivant Sciences Announces Positive Results for Batoclimab Studies - TipRanks

Mar 19, 2025
pulisher
Mar 12, 2025

(ROIV) Trading Signals - Stock Traders Daily

Mar 12, 2025
pulisher
Mar 11, 2025

Roivant at Leerink’s Conference: Strategic Insights and Developments By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 07, 2025

Does Roivant (ROIV) Offer an Attractive Risk Reward Opportunity? - Insider Monkey

Mar 07, 2025
pulisher
Mar 04, 2025

10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey

Mar 04, 2025
pulisher
Mar 03, 2025

Roivant Sciences Ltd. (ROIV): Among the Cash-Rich Mid Cap Stocks to Buy Now - Insider Monkey

Mar 03, 2025
pulisher
Mar 02, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Bought by New York State Common Retirement Fund - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Trend Tracker for (ROIV) - Stock Traders Daily

Mar 01, 2025
pulisher
Feb 28, 2025

Principal Financial Group Inc. Lowers Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Handelsbanken Fonder AB Trims Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Net worth of Vivek Ramaswamy: Roviant Sciences founder who is running for Ohio governor - The Times of India

Feb 27, 2025
pulisher
Feb 25, 2025

Early Warning Report Issued Pursuant to National Instrument 62‐103: Roivant announces Resignation and Replacement of Arbutus Board - The Manila Times

Feb 25, 2025
pulisher
Feb 25, 2025

Early Warning Report Issued Pursuant to National Instrument 62?103: Roivant announces Resignation and Replacement of Arbutus Board - Lelezard

Feb 25, 2025
pulisher
Feb 24, 2025

Roivant Sciences president Eric Venker sells $1.07 million in shares - Investing.com India

Feb 24, 2025
pulisher
Feb 21, 2025

Roivant Sciences appoints new Principal Accounting Officer By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Roivant Sciences appoints new Principal Accounting Officer - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

Roivant Sciences Appoints New Chief Accounting Officer - TipRanks

Feb 21, 2025
pulisher
Feb 20, 2025

Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So. - The Motley Fool

Feb 20, 2025
pulisher
Feb 19, 2025

Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) CAO Sells 227,500 Shares of Stock - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Long Term Trading Analysis for (ROIV) - Stock Traders Daily

Feb 19, 2025
pulisher
Feb 19, 2025

Roivant Sciences’ chief accounting officer sells $2.37 million in shares - Investing.com India

Feb 19, 2025
pulisher
Feb 18, 2025

Roivant Sciences' chief accounting officer sells $2.37 million in shares By Investing.com - Investing.com Canada

Feb 18, 2025
pulisher
Feb 18, 2025

Roivant Sciences’ chief accounting officer sells $2.37 million in shares By Investing.com - Investing.com Nigeria

Feb 18, 2025
pulisher
Feb 18, 2025

Roivant Sciences' chief accounting officer sells $2.37 million in shares - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) COO Eric Venker Sells 218,041 Shares - MarketBeat

Feb 18, 2025
pulisher
Feb 16, 2025

Roivant Sciences president Eric Venker sells over $4.56 million in stock - MSN

Feb 16, 2025
pulisher
Feb 15, 2025

Roivant Sciences president Eric Venker sells over $4.56 million in stock By Investing.com - Investing.com South Africa

Feb 15, 2025
pulisher
Feb 14, 2025

Roivant Sciences (NASDAQ:ROIV) Shares Gap Up After Earnings Beat - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

178,853 Shares in Roivant Sciences Ltd. (NASDAQ:ROIV) Acquired by Elevate Capital Advisors LLC - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

Roivant Sciences (NASDAQ:ROIV) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

Roivant Sciences: Earnings Reveal Strategic Clinical Advances - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Roivant Sciences targets brepocitinib expansion with new cutaneous sarcoidosis trial amid $5.2B cash position - MSN

Feb 13, 2025
pulisher
Feb 12, 2025

Roivant Sciences price target lowered to $12 from $13 at BofA - Yahoo Finance

Feb 12, 2025
pulisher
Feb 12, 2025

Roivant Sciences Ltd. (ROIV): A Cheap Biotech Stock to Invest In Now - Insider Monkey

Feb 12, 2025
pulisher
Feb 12, 2025

Roivant Sciences Insiders Sold US$52m Of Shares Suggesting Hesitancy - Simply Wall St

Feb 12, 2025
$78.94
price up icon 2.53%
$318.85
price up icon 1.51%
$33.41
price up icon 0.00%
$20.11
price up icon 1.41%
$99.27
price up icon 0.31%
biotechnology ONC
$266.26
price up icon 1.87%
Cap:     |  Volume (24h):